Professional Documents
Culture Documents
Textbook Infectious Diseases Emergencies 1St Edition Bissonette Ebook All Chapter PDF
Textbook Infectious Diseases Emergencies 1St Edition Bissonette Ebook All Chapter PDF
Edition Bissonette
Visit to download the full and correct content document:
https://textbookfull.com/product/infectious-diseases-emergencies-1st-edition-bissonett
e/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://textbookfull.com/product/red-book-2018-2021-report-of-
the-committee-on-infectious-diseases-american-academy-of-
pediatrics-committee-on-infectious-diseases/
https://textbookfull.com/product/emergency-management-of-
infectious-diseases-rachel-l-chin/
https://textbookfull.com/product/infectious-diseases-an-evidence-
based-approach-vikas-mishra/
https://textbookfull.com/product/infectious-diseases-a-case-
study-approach-jonathan-cho/
Infectious Diseases and Our Planet 5th Edition Rolf
Torstendahl
https://textbookfull.com/product/infectious-diseases-and-our-
planet-5th-edition-rolf-torstendahl/
https://textbookfull.com/product/canine-infectious-diseases-self-
assessment-color-review-1st-edition-katrin-hartmann/
https://textbookfull.com/product/mathematical-modelling-and-
analysis-of-infectious-diseases-khalid-hattaf/
https://textbookfull.com/product/pediatric-transplant-and-
oncology-infectious-diseases-1st-edition-william-j-steinbach-md/
https://textbookfull.com/product/genetics-and-evolution-of-
infectious-diseases-2nd-edition-michel-tibayrenc-editor/
i
Infectious Disease
Emergencies
ii
iii
Infectious Disease
Emergencies
Edited by
Andrew H. Bissonette, MD
Fellow, Emergency Medicine and Internal Medicine
Henry Ford Hospital
Detroit, Michigan
Sanjay V. Desai, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Shannon B. Putman, MD
Assistant Professor of Emergency Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
1
iv
1
Oxford University Press is a department of the University of Oxford. It furthers
the University’s objective of excellence in research, scholarship, and education
by publishing worldwide. Oxford is a registered trade mark of Oxford University
Press in the UK and certain other countries.
Published in the United States of America by Oxford University Press
198 Madison Avenue, New York, NY 10016, United States of America.
© Oxford University Press 2017
All rights reserved. No part of this publication may be reproduced, stored in
a retrieval system, or transmitted, in any form or by any means, without the
prior permission in writing of Oxford University Press, or as expressly permitted
by law, by license, or under terms agreed with the appropriate reproduction
rights organization. Inquiries concerning reproduction outside the scope of the
above should be sent to the Rights Department, Oxford University Press, at the
address above.
You must not circulate this work in any other form
and you must impose this same condition on any acquirer.
Library of Congress Cataloging-in-Publication Data
Names: Chanmugam, Arjun S., editor. | Rothman, Richard, MD, editor. | Desai, Sanjay V., editor. |
Putman, Shannon B., editor.
Title: Infectious disease emergencies / edited by Arjun S. Chanmugam, Richard Rothman,
Sanjay V. Desai, Shannon B. Putman.
Other titles: Infectious disease emergencies (Chanmugam)
Description: Oxford ; New York : Oxford University Press, [2016] |
Includes bibliographical references and index.
Identifiers: LCCN 2016002340 | ISBN 9780199976805 (alk. paper) | ISBN 9780199976829 (e-ISBN)
Subjects: | MESH: Communicable Diseases | Emergencies
Classification: LCC RC112 | NLM WC 100 | DDC 616.9/0425—dc23
LC record available at http://lccn.loc.gov/2016002340
This material is not intended to be, and should not be considered, a substitute for medical or other professional
advice. Treatment for the conditions described in this material is highly dependent on the individual
circumstances. And, while this material is designed to offer accurate information with respect to the subject
matter covered and to be current as of the time it was written, research and knowledge about medical and
health issues is constantly evolving and dose schedules for medications are being revised continually, with
new side effects recognized and accounted for regularly. Readers must therefore always check the product
information and clinical procedures with the most up-to-date published product information and data sheets
provided by the manufacturers and the most recent codes of conduct and safety regulation. The publisher
and the authors make no representations or warranties to readers, express or implied, as to the accuracy
or completeness of this material. Without limiting the foregoing, the publisher and the authors make no
representations or warranties as to the accuracy or efficacy of the drug dosages mentioned in the material.
The authors and the publisher do not accept, and expressly disclaim, any responsibility for any liability, loss or
risk that may be claimed or incurred as a consequence of the use and/or application of any of the contents of
this material.
9 8 7 6 5 4 3 2 1
Printed by WebCom, Inc., Canada
╇ v
Contents
13 Odontogenic Infections
Gabrielle Jacquet and Lawrence Page 69
14 Deep Space Infections of the Head and Neck
Gabrielle Jacquet 73
65 Plague
Trisha Anest, and David Scordino 381
66 Viral Hemorrhagic Fevers (Ebola, Lassa, Hantavirus)
Marcos Schechter 387
67 Tularemia
Alida Gertz 393
Series Preface
Emergency physicians care for patients with any condition that may be encountered in an emergency
department. This requires that they know about a vast number of emergencies, some common and
many rare. Physicians who have trained in any of the subspecialties—cardiology, neurology, obstetrics
and gynecology, and many others—have narrowed their fields of study, allowing their patients to benefit
accordingly. The Oxford University Press Emergencies series has combined the very best of these two
knowledge bases, and the result is the unique product you are now holding. Each handbook is authored
by an emergency physician and a subspecialist, allowing the reader instant access to years of expertise in
a rapid access, patient-centered format. Together with evidence-based recommendations, you will have
access to their tricks of the trade as well as the combined expertise and approaches of a subspecialist
and an emergency physician.
Patients in the emergency department often have quite different needs and require different testing
from those with a similar emergency who are in-patients. These stem from different priorities; in the
emergency department, the focus is on quickly diagnosing an undifferentiated condition. An emergency
occurring to an in-patient may also need to be newly diagnosed, but usually the information available
is more complete and the emphasis can be on a more focused and in-depth evaluation. The authors of
each Handbook have produced a guide for you wherever the patient is encountered, whether in an out-
patient clinic, urgent care, emergency department, or on the wards.
A special thanks should be extended to Andrea Knobloch, Senior Editor for Medicine at Oxford
xi
University Press, for her vision in bringing this series to press. Andrea is aware of how new electronic
media have impacted the learning process for physician-assistants, medical students, residents, and fel-
lows, yet, at the same time, she is a firm believer in the value of the printed word. This series contains the
proof that such a combination is still possible in the rapidly changing world of information technology.
Over the last 20 years, the Oxford Handbooks have become an indispensable tool for those in all
stages of training throughout the world. This new series will, I am sure, quickly grow to become the
standard reference for those who need to help their patients when faced with an emergency.
Jeremy Brown, MD
Series Editor
Associate Professor of Emergency Medicine
The George Washington University Medical Center
xii
xiii
Preface
The history of medicine can be linked to the battle against infectious disease. A striking historical example
is found within the Edwin Smith papyrus, which describes the management of 48 medical cases dating to
about 1600 bce. Impressively, this ancient document may date back much further, as the writings are often
attributed to Imhotep, the great architect and chief physician from the Old Kingdom, 3000–2500 bce.
Within the papyrus are instructions on a number of medical and surgical interventions, but the inclusion
of treating and preventing infection figures prominently. The struggle against infection is indeed almost
as old as the history of human kind.
The challenges of preventing, diagnosing, and treating infection continue to be a significant part of
medical practice today. In the acute care setting, especially emergency departments, urgent care cen-
ters, and hospitals, diagnosing and treating infectious diseases is a prime concern. Providing the correct
antibiotic or medical intervention after recognizing that an infection is present can be a complicated and
often time-consuming process. One of the key steps to correctly managing an infection is to have an
understanding of the causes, the associated recommended therapies, and the typical disease course.
This can be even more challenging in the acute setting where time limitations and comorbidities com-
plicate matters.
Although there are a number of excellent references available to medical practitioners, a concise text
that rapidly summarizes the key points of various infectious diseases, especially as it relates to acute
care management, is still in demand. The battle against infectious disease will likely be ongoing, as new
xiii
antibiotics and chemotherapeutics are introduced, as organisms develop resistance, and other defense
mechanisms evolve along with new microbial threats. A succinct reference that provides a rapid under-
standing of the basic interventions and basic process to manage infections can only help to formulate
appropriate initial strategies. In the emergency department, in urgent care centers, in hospitals, and in
clinicians’ offices, having such a reference could make a difference in making the correct diagnosis and
starting the proper treatment in a timely fashion.
The practice of medicine will likely always include a need to consider infectious processes as they con-
tribute to the morbidity and mortality of our patients. To that end, we designed this reference to be
used by clinicians everywhere and to be one more effective reference tool in the battle against infectious
disease.
xiv
xv
Acknowledgments
With thanks to Dr. Richard Rothman for his guidance and contributions to this book.
xv
xvi
xvii
Contributors
CONTRIBUTORS
Fellow, Gastroenterology Sr. Physician Assistant
University of Washington The Johns Hopkins University School of Medicine
Seattle, Washington Baltimore, Maryland
Richard Rothman, MD, PhD Mark Tenforde, MD, MPH
Professor of Emergency Medicine Division of Allergy and Infectious Diseases
The Johns Hopkins University School of Medicine University of Washington School of Medicine
Baltimore, Maryland Seattle, Washington
Sudip Saha, MD Ximena Tobar MMS, PA-C
Cardiology Fellow Sr. Physician Assistant
Beth Israel Deaconess Medical Center The Johns Hopkins University School of Medicine
Boston, Massachusetts Baltimore, Maryland
Sarina Sahetya, MD Susan Tuddenham, MD, MPH
Postdoctoral Fellow Fellow, Infectious Diseases
Pulmonary and Critical Care Medicine Johns Hopkins University, School of Medicine
Johns Hopkins Hospital Baltimore, Maryland
Baltimore, Maryland
Vanessa Vasquez, MD
Gino Scalabrini Emergency Physician
Johns Hopkins University School of Medicine West Palm, Florida
Baltimore, Maryland
Michael Vulfovich
Marcos Schechter, MD Director of Medical Education
Fellow, Infectious Diseases Department of Emergency Medicine xix
Emory University Metrowest Physicians
Atlanta, Georgia Framingham, Massachusetts
David Scordino, MD Deanna Wilson
Instructor of Emergency Medicine Adolescent Health Program
Johns Hopkins University, School of Medicine Johns Hopkins University
Baltimore, Maryland Baltimore, Maryland
Michelle Sharp Raymond Young, MD
Fellow, Pulmonary and Critical Care Fellow, Cardiovascular Medicine
Johns Hopkins University Georgetown University
Baltimore, Maryland Washington, DC
Zach Smith, MMS, PA-C
University of Maryland Medical Center
R. Adams Cowley Shock Trauma Center
Critical Care Resuscitation Unit
Baltimore, Maryland
xx
1
Section I
Principals of Infectious
Disease Management
2
3
Chapter 1
Laboratory Modalities 4
Viral Testing 4
Bacterial Testing 5
Sexually Transmitted Infections 6
Parasitic Infection 7
Fungal 7
3
4
Laboratory Modalities
The approach to microbial detection in patients who present to the emergency department (ED) should
be focused and should aim for clinically significant findings while minimizing the chances of a clinically
deleterious false negative result. Judicious selection of laboratory tests, efficient sample collection, and
laboratory reporting are all important considerations. In this chapter, general guidelines are provided for
the initial evaluation of potential microbial infections in patients presenting to the ED. In some cases, the
diagnosis will remain uncertain during the patient’s stay, but diagnostic testing initiated in the ED may be
beneficial for the inpatient or outpatient team and for the future care of the patient.
The methodology of point of care testing (POCT) differs from that of core laboratory testing. POCT
is diagnostic testing performed at or near the site of clinical care delivery. It provides the advantage of
rapid test results with the potential for faster patient treatment. When used appropriately, it typically has
high sensitivity and, thus, is an effective screening tool in the ED. The disadvantage of POCT is its lower
specificity. Some POCT is useful in the identification of certain specific organisms that cause infectious
disease, including group A Streptococcus (rapid Strep test or RST), HIV (human immunodeficiency virus),
Influenzavirus A and B, and human respiratory syncytial virus (RSV). Other POCT can also help assess for
the likelihood of a non-specific microbe being present, such as the urine dipstick.
Reverse transcriptase (RT) polymerase chain reaction (PCR; RT-PCR) is one of the more well-
developed molecular techniques to date and has a wide range of clinical applications: specific or broad-
spectrum pathogen detection, evaluation of emerging novel infections, surveillance, early detection of
bioterrorism agents, and antimicrobial resistance profiling. In regard to emergency care, PCR-based
methods are often cost-effective with excellent sensitivity and specificity profiles, and they have a rapid
turnaround time relative to traditional testing procedures.
4 Direct fluorescent antibody (DFA) testing is designed to specifically target antigens unique to the
infecting organism but not present in the human host. This technique can be used to quickly determine
if a subject has a specific viral, bacterial, or parasitic infection. These immunoassays are cost-effective,
highly specific (99% in some cases), and, generally, moderately sensitive (84% in some cases). Because
of this, DFA tests can be used for both screening and confirmation at a fraction of the turnaround time
and cost of other forms of definitive microbial testing.
Viral Testing
The vast majority of viral infections affecting immunocompetent populations rarely pose significant
morbidity or mortality risks. Therefore, with certain exceptions, there is little gained from viral test-
ing initiated during an ED visit. Some exceptions include suspected cases of meningitis or encephalitis,
respiratory infections of epidemiologic significance (ie, SARS), viral sexually transmitted diseases, and
infectious mononucleosis (IM) in patients at risk for complications.
Certain viral respiratory infections like Influenzavirus and SARS coronavirus are on the forefront of public
consciousness because these viruses have the potential to cause large-scale epidemics. Given the rise in
concern about recent influenza pandemics, the CDC (Centers for Disease Control and Prevention) and
other infectious disease governing bodies have established testing recommendations for patients with
febrile respiratory illness.
Testing for Influenzavirus infections should be initiated with a screening test such as rapid antigen test-
ing (RAT). A positive RAT is most likely to represent a truly positive patient during peak influenza sea-
son. Likewise, when influenza season has passed, negative RAT most likely represents a true negative
patient, and confirmatory testing is not needed. However, due to the limited sensitivity of RAT, a nega-
tive Influenzavirus screen during peak flu season should be interpreted with caution, and a confirmatory
test should be sent. The test of choice for diagnosing Influenzavirus infection is DFA. DFA is highly sensi-
tive and specific when compared to a viral culture, and it is timely and cost-effective. Turnaround time
typically is 24 to 48 hours.
The additional advantage of RT-PCR is its ability to type and subtype strains of Influenzavirus (eg, H1N1
or H5N1). A viral culture may be useful for public health surveillance but has no utility for ED care.
RSV infections can be diagnosed with reasonable accuracy based on clinical features during winter
months. Laboratory confirmation should only be sent during treatment to confirm diagnosis but not nec-
essarily used to guide a decision to treat. Nasopharyngeal washings followed by rapid antigen assays are
generally diagnostic (sensitivity and specificity of 90%). PCR-based assays are a reasonable alternative
to culture for confirming the rapid antigen detection assay results. Turnaround time is 24 to 48 hours.
The respiratory viral panel is a molecular assay that detects multiple viral pathogens. It is used to con-
firm negative screening tests (eg, rapid antigen assay). These panels typically detect Influenzavirus A and
5
B and RSV as well as adenovirus, rhinovirus, and parainfluenza virus species/subtypes. Turnaround time
Bacterial Testing
Bacterial sources of infection are far-reaching, affect all ages, and are the cause of significant morbidity
and mortality around the globe. An important part of initiating care for these patients includes localizing
the source of infection in order to gain source control and identifying the pathogen in order to provide
appropriate treatment. Common sources for the spread of bacterial infection include cerebrospinal fluid
(CSF), blood, urine, oropharyngeal, pulmonary, intra-abdominal, bone, and soft-tissue infections. In this
chapter, testing for specific bacterial infections is organized by localization.
Chapter 1
Suspected central nervous system (CNS) bacterial infections require special attention. Depending on
a patient’s clinical presentation, a screening head computed tomography (CT) may be warranted prior
to obtaining CSF for analysis. Head CT is recommended for patients with alterations in mental status,
papilledema (or other signs of pupillary reactions), or focal neurologic changes in order to assess for the
likelihood of potential cerebral herniation if a lumbar puncture (LP) were performed. Analysis of CSF
by way of lumbar puncture is the test of choice when evaluating a patient for a CNS infection. Some
CSF findings are highly suggestive of bacterial meningitis, but there are a variety of deviations from the
standard findings. It is important to note that CSF pleocytosis can result from noninfectious situations, 5
including traumatic LP, seizure, or subarachnoid hemorrhage. A correction factor can be used to further
clarify whether the measured white blood cell (WBC) elevations in sample CSF are the result of a trau-
matic LP or are truly representative of the WBC in the patient’s CSF (Equation 1.1).
Gram stain can suggest a bacterial etiology (when positive) 24 hours earlier than culture results.
However, CSF culture remains a gold standard for diagnosing and guiding treatment of CNS infections.
Direct bacterial antigen detection is available for rapid detection of the more concerning causes of bac-
terial CSF infection (e.g. Streptococcus pneumoniae, Haemophilus influenzae type B, group B Streptococcus,
and Neisseria meningitidis). However, these tests have been shown to be of limited sensitivity, and they
are not cost-effective. Moreover, they rarely change management because neonates, non-immunized
individuals, and many patients suspected of having bacterial meningitis should receive antibiotic treat-
ment regimens empirically for these pathogens when they are suspected.
Bacterial causes of pharyngitis can lead to significant morbidity in the acute phase of the illness, and
long-term complications can result from pharyngeal streptococcal infections. A peritonsillar or retro-
pharyngeal abscess can lead to upper airway obstruction or extension of the infection through fascial
planes, potentially leading to CNS infection, mediastinitis, and even cervical osteomyelitis in the right
circumstances.
The most widely recommended testing strategy for the detection of group A beta-hemolytic
Streptococcus (GABHS) in pediatrics is an RST specific for Streptococcus antigen in order to screen for
infection in patients presenting with symptoms consistent with strep infection, including scarlatiniform
rash. Negative RSTs in pediatric patients should be followed by a throat culture given the risk of false
negatives, but positive RSTs are reliable and are grounds for initiating treatment. Cultures are not use-
ful 2–3 weeks post infection. Given a lower prevalence of Streptococcus in adults, a negative RST yields
a sufficient negative predictive value to forgo throat culture. Cultures are not recommended for a test
of cure after treatment because they may remain positive due to a low-level carriage state (ie, some
patients are chronically colonized by GABHS without clinical consequence). RST has a turnaround time
of 3 to 5 minutes.
In contrast, throat culture has a turnaround time of 24 to 48 hours, and an additional 24 hours is
required for isolation and identification from contaminated specimens. For the evaluation of patients
suspected of having poststreptococcal disease (ie, rheumatic fever or glomerulonephritis), streptozyme,
6
antistreptolysin O (ASO), and anti-DNase B (antideoxyribonuclease B or ADB) titers are used to estab-
Principals of Infectious Disease Management
Herpes is generally a clinical diagnosis, but microbial testing can be warranted when isolation of
Chapter 1
nontreponemal tests (ie, rapid plasma reagin [RPR] or the venereal disease research laboratory [VDRL])
are used as screening tests and can be used to follow the response to treatment. Treponemal tests (TP-
PA [treponema pallidum particle agglutination], FTA-ABS [fluorescent treponemal antibody-absorbed],
and MHA-TP [microhemagglutination assay for antibodies to treponema pallidum]) are used for con-
firmation of a reactive nontreponemal test. In other words, when a VDRL or RPR screen for syphilis is
positive (reactive), then confirmation testing with one of the direct treponemal tests is indicated.
7
Parasitic Infection
Parasite and vector-related infections cause a great deal of morbidity and mortality worldwide but rarely
impact the United States on a large scale. However, there are a few notable infections. Malaria, babe-
siosis, Chagas disease, and leishmaniasis are parasitic infections that can be detected in peripheral blood
samples. Testing for these parasites requires thick and thin smears, which are inspected for the level of
parasitemia. The turnaround time for a positive smear is around 24 hours. If malaria is suspected, a STAT
(signal transducer and activator of transcription) preliminary result should be ordered. STAT testing can
result in less than 4 hours. Repeat samples should be sent during malaria treatment after 24, 48, and 72
hours to assess the effectiveness of therapy by trending the decline of parasitemia.
Borrelia burgdorferi is a tick-borne disease that is classically diagnosed clinically without laboratory test-
ing. In some cases, testing can help if Lyme disease is suspected in at-risk patients. If laboratory testing is
performed, an ELISA antibody screen is used for the detection of IgG or IgM antibodies. False negatives
are common in the first one to two weeks of infection because it can take time to create a measurable
concentration of antibodies against B. burgdorferi. If the ELISA is positive or inconclusive, a Western
blot should be done to confirm infection. This two-tiered approach is recommended by the CDC to
minimize false positive findings.
Fungal
Cultures are the most sensitive routine laboratory method for the detection of fungal infections. Fungal
culture is indicated in patients who are immunocompromised, septic and receiving extensive treatment
with broad-spectrum antibiotics, and, sometimes, victims of severe trauma. Fungal cultures are rarely
sent from the ED but should be considered in patients who have a lack of response to appropriate anti-
bacterial treatment. Cultures for yeast are incubated for seven days, whereas routine fungal cultures are
incubated for up to four weeks.
4. Slaven EM, Stone SC, Lopez FA. Infectious Diseases: Emergency Department Diagnosis and Management.
Principals of Infectious Disease Management
8
Another random document with
no related content on Scribd:
the world. He has carried on that controversy since his Balliol days.
The exigencies that oblige him to pretend, against his better
knowledge and common civility, that I am petty and provincial and
patriotic and wilfully ignorant and pitifully out-of-date, oblige him to
pretend as much about most of those who stand for modern science
and a modern interpretation of history. He would pretend as hard
about Sir Ray Lankester, for example, or about Professor Gilbert
Murray or Sir Harry Johnston or Professor Barker, as he does about
me. It is a general system of pretence. It is a necessary part of—I will
not say of the Catholic attitude, but of his Catholic attitude towards
modern knowledge.
The necessity for a pose involving this pretence is not very
difficult to understand. Long before Mr. Belloc embarked upon the
present dispute he had become the slave of a tactical fiction, which
reiteration had made a reality for him. He evoked the fiction as early,
I believe, as his Oxford days. It may have been very effective at
Oxford—among the undergraduates. Then perhaps it was
consciously a defensive bluff, but certainly it is no longer that. He
has come at last to believe absolutely in this creature of his
imagination. He has come to believe this: that there is a vast
“modern European” culture of which the English-speaking world
knows nothing, of which the non-Catholic world knows nothing, and
with which he is familiar. It is on his side. It is always on his side. It is
simply and purely Belloccian. He certainly believes it is there. It
sustains his faith. It assuages the gnawing attacks of self-criticism
that must come to him in the night. Throughout these papers he is
constantly referring to this imaginary stuff—without ever coming to
precisions. Again and again and again and again—and again and
again and again, he alludes to this marvellous “European” science
and literature, beyond our ken.
He does not quote it; it does not exist for him to quote; but he
believes that it exists. He waves his hand impressively in the
direction in which it is supposed to be. It is his stand-by, his refuge,
his abiding fortress. But, in order to believe in it, it is necessary for
him to believe that no other English-speaking men can even read
French, and that their scepticism about it is based on some
“provincial” prejudice or some hatred of Catholics, or southern
people, or “Dagoes,” or “foreigners,” or what you will. That is why
Nature wilfully ignores the wonderful science of this “Europe”; and
why our Royal Society has no correspondence with it. But he has to
imagine it is there and make his readers imagine it is there, and that
there is this conspiracy of prejudice to ignore it, before he can even
begin to put up any appearance of a case against such a résumé of
current knowledge as the Outline of History.